Vera Therapeutics, Inc. (VERA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.25B |
| Enterprise Value | 2.98B |
| P/E Ratio | -5.09 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 211.26 |
| Price/Book Ratio | 6.5 |
| Enterprise/Revenue | 213.22 |
| Enterprise/EBITDA | -5.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -40.41 |
| Operating Margin | -41.6 |
| Return On Assets | -0.89 |
| Return On Equity | -0.9 |
| Revenue | 0 |
| Revenue/Share | 0.14 |
| Gross Profit | 0 |
| EBITDA | -291.62M |
| Net Income | -299.62M |
| Diluted EPS | -4.66 |
| Total Cash | 384.04M |
| Total Cash/Share | 5.32 |
| Total Debt | 75.43M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 7.91 |
| Book Value Per Share | 4.62 |
| 52-Week Change | 1.08 |
| 52-Week High | 56.05 |
| 52-Week Low | 26.38 |
| Moving Average 50 Days | 31.45 |
| Moving Average 200 Days | 36.39 |
| Average Volume | 2.07M |
| Shares Outstanding | 72.3M |
| % Held by Institutions | 109.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |